HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yan, Z. Articles by Friedman, E. Search for Related Content PubMed PubMed Citation Articles by Yan, Z. Articles by Friedman, E. Social Bookmarking                      What's this?

Volume 272, Number 44, Issue of October 31, 1997 pp. 27902-27907
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Oncogenic c-Ki-ras but Not Oncogenic c-Ha-ras Up-regulates CEA Expression and Disrupts Basolateral Polarity in Colon Epithelial Cells

(Received for publication, May 22, 1997, and in revised form, July 24, 1997)

Zhongfa Yan , Xiaobing Deng , Mingxing Chen , Ying Xu , Mamoun Ahram ^§ , Bonnie F. Sloane ^§¶ and Eileen Friedman

From the  Department of Pathology, State University of New York Health Science Center, Syracuse, New York 13210-2399 and the ^¶ Department of Pharmacology and ^§ Cancer Biology Program, Wayne State University, Detroit, Michigan 48201

Colon carcinomas commonly contain mutations in Ki-ras4B, but very rarely in Ha-ras, suggesting that different Ras isoforms may have distinct functions in colon epithelial cell biology. In an earlier study we had demonstrated that oncogenic Ki-ras4B^Val-12, but not oncogenic Ha-ras^Val-12, blocks the apicobasal polarization of colon epithelial cells by preventing normal glycosylation of the integrin 1 chain of the collagen receptor. As a result, only the Ki-ras mutated cells exhibited altered cell to substratum attachment, whereas mutation of either Ras isoform activated mitogen-activated protein kinases. We have now asked whether intercellular adhesion proteins implicated in establishing basolateral polarity in colon epithelial cells are modulated by oncogenic Ki-Ras4B^Val-12 proteins but not oncogenic Ha-Ras^Val-12 proteins. The embryonic adhesion protein carcinoembryonic antigen (CEA) was up-regulated on the mRNA and protein levels in each of three stable Ki-ras^Val-12 transfectant lines but in none of three stable Ha-ras^Val-12 transfectant lines. The elevated protein levels of CEA in Ki-ras4B^Val-12 transfectant cells were decreased by blocking expression of Ki-ras4B^Val-12 with antisense oligonucleotides. N-cadherin levels were decreased in only the Ki-ras transfectants, whereas E-cadherin levels were unchanged. Immunohistochemical analysis demonstrated that Ki-ras4B^Val-12 transfectant cells did not polarize into cells with discrete apical and basal regions and so could not restrict expression of CEA to the apical region. These unpolarized cells displayed elevated levels of CEA all along their surface membrane where CEA mediated random, multilayered associations of tumor cells. This aggregation was both calcium-independent and blocked by Fab fragments of anti-CEA monoclonal antibody col-1. Trafficking of the lysosomal cysteine protease cathepsin B may also be altered when cell polarity cannot be established. Ki-ras4B^Val-12 transfectant cells expressed 2-fold elevated protein levels of the lysosomal cysteine protease cathepsin B but did not up-regulate cathepsin B mRNA expression. One function of oncogenic c-Ki-Ras proteins in colon cancer progression may be to up-regulate CEA and thus to prevent the lateral adhesion of adjacent colon epithelial cells that normally form a monolayer in vivo.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. B. Fleming, G.-L. Shen, S. E. Holloway, M. Davis, and R. A. Brekken Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras-Directed Therapy Mol. Cancer Res., July 1, 2005; 3(7): 413 - 423. [Abstract] [Full Text] [PDF]

				P. Jay, P. Berta, and P. Blache Expression of the Carcinoembryonic Antigen Gene Is Inhibited by SOX9 in Human Colon Carcinoma Cells Cancer Res., March 15, 2005; 65(6): 2193 - 2198. [Abstract] [Full Text] [PDF]

				P. Jantscheff, L. Terracciano, A. Lowy, K. Glatz-Krieger, F. Grunert, B. Micheel, J. Brummer, U. Laffer, U. Metzger, R. Herrmann, et al. Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance J. Clin. Oncol., October 1, 2003; 21(19): 3638 - 3646. [Abstract] [Full Text] [PDF]

				Z. Yan, G.-Y. Kim, X. Deng, and E. Friedman Transforming Growth Factor beta 1 Induces Proliferation in Colon Carcinoma Cells by Ras-dependent, smad-independent Down-regulation of p21cip1 J. Biol. Chem., March 15, 2002; 277(12): 9870 - 9879. [Abstract] [Full Text] [PDF]

				P. J. Ross, M. George, D. Cunningham, F. DiStefano, H. J. N. Andreyev, P. Workman, and P. A. Clarke Inhibition of Kirsten-ras Expression in Human Colorectal Cancer Using Rationally Selected Kirsten-ras Antisense Oligonucleotides Mol. Cancer Ther., November 1, 2001; 1(1): 29 - 41. [Abstract] [Full Text] [PDF]

				A. Rebollo and C. Martinez-A Ras Proteins: Recent Advances and New Functions Blood, November 1, 1999; 94(9): 2971 - 2980. [Full Text] [PDF]

				Z. Yan, X. Deng, and E. Friedman Oncogenic Ki-ras Confers a More Aggressive Colon Cancer Phenotype through Modification of Transforming Growth Factor-beta Receptor III J. Biol. Chem., January 5, 2001; 276(2): 1555 - 1563. [Abstract] [Full Text] [PDF]

				A. B. Walsh and D. Bar-Sagi Differential Activation of the Rac Pathway by Ha-Ras and K-Ras J. Biol. Chem., May 4, 2001; 276(19): 15609 - 15615. [Abstract] [Full Text] [PDF]

				R. A. Gupta, J. A. Brockman, P. Sarraf, T. M. Willson, and R. N. DuBois Target Genes of Peroxisome Proliferator-activated Receptor gamma in Colorectal Cancer Cells J. Biol. Chem., August 3, 2001; 276(32): 29681 - 29687. [Abstract] [Full Text] [PDF]